Recall of drospirenone and ethinyl estradiol tablets, USP, 3 mg/ 0.02mg by Jubilant Cadista Pharmaceuticals due to out of specification (OOS) dissolution results.
More on the FDA website.
Recall of drospirenone and ethinyl estradiol tablets, USP, 3 mg/ 0.02mg by Jubilant Cadista Pharmaceuticals due to out of specification (OOS) dissolution results.
More on the FDA website.